EPTINEZUMAB FOR PREVENTION OF CHRONIC MIGRAINE (CM): RESULTS OF 2 INFUSIONS IN THE PHASE 3 PROMISE-2 (PREVENTION OF MIGRAINE VIA INTRAVENOUS EPTINEZUMAB SAFETY AND EFFICACY-2) TRIAL

被引：0

作者：

Ashina, M. ^{[1
]}

Goadsby, P. J. ^{[2
]}

Lipton, R. B. ^{[3
]}

Azimova, J. ^{[4
]}

Winner, P. ^{[5
]}

Schaeffler, B. ^{[6
]}

Biondi, D. ^{[6
]}

Bhattacharya, S. ^{[6
]}

Smith, J. ^{[7
]}

Cady, R. ^{[6
]}

机构：

[1] Univ Copenhagen, Rigshosp Glostrup, Danish Headache Ctr, Copenhagen, Denmark

[2] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England

[3] Albert Einstein Coll Med, Montefiore Headache Ctr, Bronx, NY 10467 USA

[4] Univ Headache Clin, Moscow, Russia

[5] Palm Beach Headache Ctr, Premiere Res Inst, W Palm Beach, FL USA

[6] Alder BioPharmaceut Inc, Bothell, WA USA

[7] Alder BioPharmaceut Inc, Dublin, Ireland

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

MTIS2018-0

引用

页码：84 / 85

页数：2